|
Volumn 12, Issue 9, 1993, Pages 835-842
|
Evaluating the role of CD4‐lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials
a b c |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD4 ANTIGEN;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
DISEASE COURSE;
DRUG EFFICACY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
LABORATORY TEST;
LYMPHOCYTE COUNT;
MAJOR CLINICAL STUDY;
OPPORTUNISTIC INFECTION;
REGRESSION ANALYSIS;
STATISTICAL ANALYSIS;
SURVIVAL TIME;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AIDS-RELATED COMPLEX;
CD4-POSITIVE T-LYMPHOCYTES;
CLINICAL TRIALS;
HIV INFECTIONS;
HIV-1;
HUMAN;
LEUKOCYTE COUNT;
SUPPORT, U.S. GOV'T, P.H.S.;
SURVIVAL RATE;
ZIDOVUDINE;
|
EID: 0027160462
PISSN: 02776715
EISSN: 10970258
Source Type: Journal
DOI: 10.1002/sim.4780120904 Document Type: Article |
Times cited : (70)
|
References (16)
|